🇺🇸 FDA
Patent

US 8703751

Androstenediol as an indicator for assessing estrogenicity

granted A61KA61K31/565A61P

Quick answer

US patent 8703751 (Androstenediol as an indicator for assessing estrogenicity) held by The Regents of the University of California expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/565, A61P, A61P15/00, A61P15/12